BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35719941)

  • 1. A Single-Center Retrospective Analysis of Local and Distant Relapse of Breast Cancer Following Immediate Breast Reconstruction According to Molecular Subtypes.
    Han C; Zhang X; Sun J; Liu J; He S; Yin J
    Front Oncol; 2022; 12():912163. PubMed ID: 35719941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of immediate breast reconstruction in young women with breast cancer receiving neoadjuvant chemotherapy.
    Wu ZY; Kim HJ; Lee J; Chung IY; Kim J; Lee SB; Son BH; Kim EK; Jeong JH; Lee HJ; Chae EY; Jung J; Ahn SH; Ko B
    Breast Cancer Res Treat; 2022 Jan; 191(2):345-354. PubMed ID: 34718930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy.
    Wu ZY; Kim HJ; Lee JW; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Jung KH; Gong G; Kim HH; Ahn SH; Ko B
    JAMA Surg; 2020 Dec; 155(12):1142-1150. PubMed ID: 33052412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.
    Wang J; Luo J; Jin K; Wang X; Yang Z; Ma J; Mei X; Wang X; Zhou Z; Yu X; Chen X; Guo X
    Cancer Med; 2020 Apr; 9(7):2427-2434. PubMed ID: 32048817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction.
    Kneubil MC; Brollo J; Botteri E; Curigliano G; Rotmensz N; Goldhirsch A; Lohsiriwat V; Manconi A; Martella S; Santillo B; Petit JY; Rietjens M
    Eur J Surg Oncol; 2013 Mar; 39(3):260-5. PubMed ID: 23313014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study.
    Wu ZY; Han J; Kim HJ; Lee JW; Chung IY; Kim J; Lee SB; Son BH; Han HH; Eom JS; Jeong JH; Gong G; Kim HH; Ahn SH; Ko B
    Breast Cancer Res Treat; 2022 Jan; 191(2):365-373. PubMed ID: 34755242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
    Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
    Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched Cohort.
    Shin DS; Bang YJ; Choi JY; Jang SY; Lee H; Kwak Y; Chae BJ; Yu J; Lee JE; Kim SW; Nam SJ; Jeon BJ; Pyon JK; Mun GH; Lee KT; Ryu JM
    J Breast Cancer; 2024 Feb; 27(1):14-26. PubMed ID: 38233336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated.
    Leonardi MC; Scognamiglio IR; Maisonneuve P; Dicuonzo S; Rojas DP; Zerella MA; Morra A; Gerardi MA; Zaffaroni M; De Scalzi A; Girardi A; Magnoni F; Montagna E; Fodor CI; Galimberti VE; Veronesi P; Orecchia R; Pacelli R; Jereczek-Fossa BA; Corso G
    Breast Cancer Res Treat; 2021 Jul; 188(2):511-524. PubMed ID: 33905020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
    Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of postmastectomy radiotherapy on pT
    Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
    Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncological safety and prognosis factors analysis of immediate breast reconstruction after nipple-areola-complex sparing mastectomy].
    Li ZJ; Zhang P; Zhang W; Zhang Z; Wang XM; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):690-695. PubMed ID: 30293396
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncologic Safety of Immediate Breast Reconstruction for Invasive Breast Cancer Patients: A Matched Case Control Study.
    Park SH; Han W; Yoo TK; Lee HB; Jin US; Chang H; Minn KW; Noh DY
    J Breast Cancer; 2016 Mar; 19(1):68-75. PubMed ID: 27064557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective cohort study comparing reconstructive techniques and outcomes in post-mastectomy triple negative breast cancer patients.
    Sayyed AA; Towfighi P; Deldar R; Aminpour N; Sogunro O; Maini M; Masanam M; Son JD; Fan KL; Song DH
    Transl Breast Cancer Res; 2023; 4():5. PubMed ID: 38751478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
    Chou HH; Chung WS; Ding RY; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Lo YF; Chen SC
    BMC Surg; 2021 Mar; 21(1):160. PubMed ID: 33757489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.
    Meyers MO; Klauber-Demore N; Ollila DW; Amos KD; Moore DT; Drobish AA; Burrows EM; Dees EC; Carey LA
    Ann Surg Oncol; 2011 Oct; 18(10):2851-7. PubMed ID: 21442348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
    Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Predicting Locoregional Recurrence After Neoadjuvant Chemotherapy and Nipple-Sparing/Skin-Sparing Mastectomy With Immediate Breast Reconstruction.
    Wu ZY; Kim HJ; Lee JW; Chung IY; Kim J; Lee SB; Son BH; Eom JS; Jeong JH; Gong G; Kim HH; Ahn SH; Ko B
    Front Oncol; 2021; 11():675955. PubMed ID: 34277421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy.
    Dominici LS; Mittendorf EA; Wang X; Liu J; Kuerer HM; Hunt KK; Brewster A; Babiera GV; Buchholz TA; Meric-Bernstam F; Bedrosian I
    Breast Cancer Res; 2012 May; 14(3):R82. PubMed ID: 22621306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.